Literature DB >> 31602191

Novel HIVEP2 Variants in Patients with Intellectual Disability.

Joohyun Park1,2, Roberto Colombo3,4, Karin Schäferhoff1,5, Luigi Janiri6,4, Mona Grimmel1,5, Marc Sturm1, Ute Grasshoff1,5, Andreas Dufke1,5, Tobias B Haack1,5, Martin Kehrer1,5.   

Abstract

Intellectual disability (ID) occurs in approximately 1% of the population. Over the last years, broad sequencing approaches such as whole exome sequencing (WES) substantially contributed to the definition of the molecular defects underlying nonsyndromic ID. Pathogenic variants in HIVEP2, which encodes the human immunodeficiency virus type I enhancer binding protein 2, have recently been reported as a cause of ID, developmental delay, behavioral disorders, and dysmorphic features. HIVEP2 serves as a transcriptional factor regulating NF-ĸB and diverse genes that are essential in neural development. To date, only 8 patients with pathogenic de novo nonsense or frameshift variants and 1 patient with a pathogenic missense variant in HIVEP2 have been reported. By WES, we identified 2 novel truncating HIVEP2 variants, c.6609_6616delTGAGGGTC (p.Glu2204*) and c.6667C>T (p.Arg2223*), in 2 young adults presenting with developmental delay and mild ID without any dysmorphic features, systemic malformations, or behavioral issues.
Copyright © 2019 by S. Karger AG, Basel.

Entities:  

Keywords:  Exome sequencing; HIVEP2; Intellectual disability; MRD43

Year:  2019        PMID: 31602191      PMCID: PMC6738162          DOI: 10.1159/000499060

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  20 in total

1.  A de novo paradigm for mental retardation.

Authors:  Lisenka E L M Vissers; Joep de Ligt; Christian Gilissen; Irene Janssen; Marloes Steehouwer; Petra de Vries; Bart van Lier; Peer Arts; Nienke Wieskamp; Marisol del Rosario; Bregje W M van Bon; Alexander Hoischen; Bert B A de Vries; Han G Brunner; Joris A Veltman
Journal:  Nat Genet       Date:  2010-11-14       Impact factor: 38.330

2.  Whole-exome sequencing in intellectual disability; cost before and after a diagnosis.

Authors:  Terry Vrijenhoek; Eline M Middelburg; Glen R Monroe; Koen L I van Gassen; Joost W Geenen; Anke M Hövels; Nine V Knoers; Hans Kristian Ploos van Amstel; Gerardus W J Frederix
Journal:  Eur J Hum Genet       Date:  2018-06-29       Impact factor: 4.246

3.  De novo FBXO11 mutations are associated with intellectual disability and behavioural anomalies.

Authors:  Daniel Fritzen; Alma Kuechler; Mona Grimmel; Jessica Becker; Sophia Peters; Marc Sturm; Hela Hundertmark; Axel Schmidt; Martina Kreiß; Tim M Strom; Dagmar Wieczorek; Tobias B Haack; Stefanie Beck-Wödl; Kirsten Cremer; Hartmut Engels
Journal:  Hum Genet       Date:  2018-05-23       Impact factor: 4.132

Review 4.  Prevalence of intellectual disability: a meta-analysis of population-based studies.

Authors:  Pallab K Maulik; Maya N Mascarenhas; Colin D Mathers; Tarun Dua; Shekhar Saxena
Journal:  Res Dev Disabil       Date:  2011-01-13

5.  Human immunodeficiency virus type 1 enhancer-binding protein 3 is essential for the expression of asparagine-linked glycosylation 2 in the regulation of osteoblast and chondrocyte differentiation.

Authors:  Katsuyuki Imamura; Shingo Maeda; Ichiro Kawamura; Kanehiro Matsuyama; Naohiro Shinohara; Yuhei Yahiro; Satoshi Nagano; Takao Setoguchi; Masahiro Yokouchi; Yasuhiro Ishidou; Setsuro Komiya
Journal:  J Biol Chem       Date:  2014-02-21       Impact factor: 5.157

Review 6.  De novo mutations in human genetic disease.

Authors:  Joris A Veltman; Han G Brunner
Journal:  Nat Rev Genet       Date:  2012-07-18       Impact factor: 53.242

7.  Combined behavioral studies and in vivo imaging of inflammatory response and expression of mGlu5 receptors in schnurri-2 knockout mice.

Authors:  Ji-Kyung Choi; Aijun Zhu; Bruce G Jenkins; Satoko Hattori; Kun-Eek Kil; Tsuyoshi Takagi; Shunsuke Ishii; Tsuyoshi Miyakawa; Anna-Liisa Brownell
Journal:  Neurosci Lett       Date:  2015-10-23       Impact factor: 3.046

8.  Healthcare costs of intellectual disability in the Netherlands: a cost-of-illness perspective.

Authors:  J J Polder; W J Meerding; L Bonneux; P J van der Maas
Journal:  J Intellect Disabil Res       Date:  2002-02

9.  High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies.

Authors:  Fadi F Hamdan; Candace T Myers; Patrick Cossette; Philippe Lemay; Dan Spiegelman; Alexandre Dionne Laporte; Christina Nassif; Ousmane Diallo; Jean Monlong; Maxime Cadieux-Dion; Sylvia Dobrzeniecka; Caroline Meloche; Kyle Retterer; Megan T Cho; Jill A Rosenfeld; Weimin Bi; Christine Massicotte; Marguerite Miguet; Ledia Brunga; Brigid M Regan; Kelly Mo; Cory Tam; Amy Schneider; Georgie Hollingsworth; David R FitzPatrick; Alan Donaldson; Natalie Canham; Edward Blair; Bronwyn Kerr; Andrew E Fry; Rhys H Thomas; Joss Shelagh; Jane A Hurst; Helen Brittain; Moira Blyth; Robert Roger Lebel; Erica H Gerkes; Laura Davis-Keppen; Quinn Stein; Wendy K Chung; Sara J Dorison; Paul J Benke; Emily Fassi; Nicole Corsten-Janssen; Erik-Jan Kamsteeg; Frederic T Mau-Them; Ange-Line Bruel; Alain Verloes; Katrin Õunap; Monica H Wojcik; Dara V F Albert; Sunita Venkateswaran; Tyson Ware; Dean Jones; Yu-Chi Liu; Shekeeb S Mohammad; Peyman Bizargity; Carlos A Bacino; Vincenzo Leuzzi; Simone Martinelli; Bruno Dallapiccola; Marco Tartaglia; Lubov Blumkin; Klaas J Wierenga; Gabriela Purcarin; James J O'Byrne; Sylvia Stockler; Anna Lehman; Boris Keren; Marie-Christine Nougues; Cyril Mignot; Stéphane Auvin; Caroline Nava; Susan M Hiatt; Martina Bebin; Yunru Shao; Fernando Scaglia; Seema R Lalani; Richard E Frye; Imad T Jarjour; Stéphanie Jacques; Renee-Myriam Boucher; Emilie Riou; Myriam Srour; Lionel Carmant; Anne Lortie; Philippe Major; Paola Diadori; François Dubeau; Guy D'Anjou; Guillaume Bourque; Samuel F Berkovic; Lynette G Sadleir; Philippe M Campeau; Zoha Kibar; Ronald G Lafrenière; Simon L Girard; Saadet Mercimek-Mahmutoglu; Cyrus Boelman; Guy A Rouleau; Ingrid E Scheffer; Heather C Mefford; Danielle M Andrade; Elsa Rossignol; Berge A Minassian; Jacques L Michaud
Journal:  Am J Hum Genet       Date:  2017-11-02       Impact factor: 11.025

10.  Exome sequencing for bipolar disorder points to roles of de novo loss-of-function and protein-altering mutations.

Authors:  M Kataoka; N Matoba; T Sawada; A-A Kazuno; M Ishiwata; K Fujii; K Matsuo; A Takata; T Kato
Journal:  Mol Psychiatry       Date:  2016-05-24       Impact factor: 15.992

View more
  3 in total

1.  Neurodevelopmental profile of HIVEP2-related disorder.

Authors:  Alisa Mo; Leeanne G Snyder; Owen Babington; Wendy K Chung; Mustafa Sahin; Siddharth Srivastava
Journal:  Dev Med Child Neurol       Date:  2021-10-26       Impact factor: 5.449

2.  Genetic Etiologies in Developmental and/or Epileptic Encephalopathy With Electrical Status Epilepticus During Sleep: Cohort Study.

Authors:  Pan Gong; Jiao Xue; Xianru Jiao; Yuehua Zhang; Zhixian Yang
Journal:  Front Genet       Date:  2021-04-08       Impact factor: 4.599

3.  Biallelic ADAM22 pathogenic variants cause progressive encephalopathy and infantile-onset refractory epilepsy.

Authors:  Marieke M van der Knoop; Reza Maroofian; Yuko Fukata; Yvette van Ierland; Ehsan G Karimiani; Anna Elina Lehesjoki; Mikko Muona; Anders Paetau; Yuri Miyazaki; Yoko Hirano; Laila Selim; Marina de França; Rodrigo Ambrosio Fock; Christian Beetz; Claudia A L Ruivenkamp; Alison J Eaton; Francois D Morneau-Jacob; Lena Sagi-Dain; Lilach Shemer-Meiri; Amir Peleg; Jumana Haddad-Halloun; Daan J Kamphuis; Cacha M P C D Peeters-Scholte; Semra Hiz Kurul; Rita Horvath; Hanns Lochmüller; David Murphy; Stephan Waldmüller; Stephanie Spranger; David Overberg; Alison M Muir; Aboulfazl Rad; Barbara Vona; Firdous Abdulwahad; Sateesh Maddirevula; Inna S Povolotskaya; Victoria Y Voinova; Vykuntaraju K Gowda; Varunvenkat M Srinivasan; Fowzan S Alkuraya; Heather C Mefford; Majid Alfadhel; Tobias B Haack; Pasquale Striano; Mariasavina Severino; Masaki Fukata; Yvonne Hilhorst-Hofstee; Henry Houlden
Journal:  Brain       Date:  2022-07-29       Impact factor: 15.255

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.